BY OUR PLATFORMS
BY THERAPEUTIC AREA
Carles Cornet - 16 November 2022
Combining a zebrafish-based high throughput platform with artificial intelligence for human developmental toxicity assessment.
Miriam Martínez - 27 July 2022
Zebrafish for regulatory purposes in ecotoxicology and safety pharmacology
Miriam Martínez - 30 June 2022
New trends and updated availability for zebrafish studies in EU and US
Javier Terriente - 19 January 2022
Use of biomarkers in endocrine disruption compounds screening and testing with zebrafish
Sylvia Dyballa - 12 May 2021
In ZeClinics we bet on emerging technologies to scale our solutions.
Sergio Jarque - 10 March 2021
From challenge to knowledge: the outstanding performance of zebrafish in predicting toxicity.
Vincenzo Di Donato - 13 January 2021
ZeClinics laboratory R&D efforts are mainly divided in the development of three research platforms including a number of research areas.